DENTSPLY SIRONA (NASDAQ:XRAY) Earns Outperform Rating from Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating restated by Barrington Research in a research report issued on Tuesday,Benzinga reports. They presently have a $21.00 price target on the medical instruments supplier’s stock. Barrington Research’s target price indicates a potential upside of 24.63% from the stock’s current price.

A number of other brokerages have also commented on XRAY. UBS Group decreased their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a research note on Friday, May 9th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Monday. Morgan Stanley cut DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price on the stock. in a research note on Tuesday, April 15th. Piper Sandler reduced their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, April 30th. Finally, Wall Street Zen upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Sunday, July 13th. Ten research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $19.60.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $16.85 on Tuesday. The stock’s 50-day moving average is $16.05 and its 200-day moving average is $16.24. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79. DENTSPLY SIRONA has a 1-year low of $12.16 and a 1-year high of $27.95. The stock has a market cap of $3.36 billion, a P/E ratio of -3.71, a price-to-earnings-growth ratio of 1.17 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company had revenue of $879.00 million during the quarter, compared to analysts’ expectations of $854.75 million. During the same period in the prior year, the company posted $0.42 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 7.8% compared to the same quarter last year. Equities research analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds have recently added to or reduced their stakes in the company. Treasurer of the State of North Carolina grew its position in DENTSPLY SIRONA by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier’s stock worth $1,686,000 after acquiring an additional 560 shares during the last quarter. Quarry LP increased its position in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock valued at $72,000 after buying an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio raised its stake in DENTSPLY SIRONA by 1.4% during the second quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock valued at $983,000 after buying an additional 861 shares during the last quarter. Federated Hermes Inc. increased its stake in DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier’s stock valued at $3,213,000 after purchasing an additional 915 shares in the last quarter. Finally, Gabelli Funds LLC raised its position in DENTSPLY SIRONA by 1.0% in the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock worth $1,464,000 after buying an additional 1,000 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.